These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 15480903

  • 1. Prevalence of high fasting plasma glucose and risk of developing end-stage renal disease in screened subjects in Okinawa, Japan.
    Iseki K, Ikemiya Y, Kinjo K, Iseki C, Takishita S.
    Clin Exp Nephrol; 2004 Sep; 8(3):250-6. PubMed ID: 15480903
    [Abstract] [Full Text] [Related]

  • 2. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
    Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S.
    Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015
    [Abstract] [Full Text] [Related]

  • 3. Relationship between dyslipidemia and the risk of developing end-stage renal disease in a screened cohort.
    Iseki K, Tozawa M, Ikemiya Y, Kinjo K, Iseki C, Takishita S.
    Clin Exp Nephrol; 2005 Mar; 9(1):46-52. PubMed ID: 15830273
    [Abstract] [Full Text] [Related]

  • 4. Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan.
    Iseki K, Kinjo K, Iseki C, Takishita S.
    Am J Kidney Dis; 2004 Nov; 44(5):806-14. PubMed ID: 15492946
    [Abstract] [Full Text] [Related]

  • 5. Risk of developing low glomerular filtration rate or elevated serum creatinine in a screened cohort in Okinawa, Japan.
    Iseki K, Iseki C, Ikemiya Y, Kinjo K, Takishita S.
    Hypertens Res; 2007 Feb; 30(2):167-74. PubMed ID: 17460387
    [Abstract] [Full Text] [Related]

  • 6. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
    Ishani A, Grandits GA, Grimm RH, Svendsen KH, Collins AJ, Prineas RJ, Neaton JD.
    J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
    [Abstract] [Full Text] [Related]

  • 7. Predictors of end-stage renal disease and body mass index in a screened cohort.
    Iseki K, Ikemiya Y, Fukiyama K.
    Kidney Int Suppl; 1997 Dec; 63():S169-70. PubMed ID: 9407450
    [Abstract] [Full Text] [Related]

  • 8. Blood pressure and risk of end-stage renal disease in a screened cohort.
    Iseki K, Ikemiya Y, Fukiyama K.
    Kidney Int Suppl; 1996 Jun; 55():S69-71. PubMed ID: 8743514
    [Abstract] [Full Text] [Related]

  • 9. Changes in the demographics and prevalence of chronic kidney disease in Okinawa, Japan (1993 to 2003).
    Iseki K, Kohagura K, Sakima A, Iseki C, Kinjo K, Ikemiya Y, Takishita S.
    Hypertens Res; 2007 Jan; 30(1):55-62. PubMed ID: 17460372
    [Abstract] [Full Text] [Related]

  • 10. Exploring secular trends in the likelihood of receiving treatment for end-stage renal disease.
    Hsu CY, Go AS, McCulloch CE, Darbinian J, Iribarren C.
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):81-8. PubMed ID: 17699391
    [Abstract] [Full Text] [Related]

  • 11. Body mass index and the risk of development of end-stage renal disease in a screened cohort.
    Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S.
    Kidney Int; 2004 May; 65(5):1870-6. PubMed ID: 15086929
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Renal outcomes in chronic kidney disease.
    Iseki K.
    Nephrology (Carlton); 2010 Jun; 15 Suppl 2():27-30. PubMed ID: 20586944
    [Abstract] [Full Text] [Related]

  • 14. Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause.
    Wakai K, Nakai S, Kikuchi K, Iseki K, Miwa N, Masakane I, Wada A, Shinzato T, Nagura Y, Akiba T.
    Nephrol Dial Transplant; 2004 Aug; 19(8):2044-52. PubMed ID: 15173379
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The current state of chronic dialysis treatment in Japan (as of December 31, 2000).
    Ther Apher Dial; 2003 Feb; 7(1):3-35. PubMed ID: 12921111
    [Abstract] [Full Text] [Related]

  • 17. Factors influencing the development of end-stage renal disease.
    Iseki K.
    Clin Exp Nephrol; 2005 Mar; 9(1):5-14. PubMed ID: 15830267
    [Abstract] [Full Text] [Related]

  • 18. Proteinuria and the risk of developing end-stage renal disease.
    Iseki K, Ikemiya Y, Iseki C, Takishita S.
    Kidney Int; 2003 Apr; 63(4):1468-74. PubMed ID: 12631363
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Direct, progressive association of cardiovascular risk factors with incident proteinuria: results from the Korea Medical Insurance Corporation (KMIC) study.
    Jee SH, Boulware LE, Guallar E, Suh I, Appel LJ, Miller ER.
    Arch Intern Med; 2005 Oct 24; 165(19):2299-304. PubMed ID: 16246998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.